Premium
CA 125 and the detection of recurrent ovarian cancer
Author(s) -
Bast Robert C.
Publication year - 2010
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.25203
Subject(s) - medicine , ovarian cancer , cancer antigen , value (mathematics) , clinical practice , cancer , oncology , gynecology , family medicine , statistics , mathematics
Rising cancer antigen 125 (CA125) levels have been used to detect recurrence of ovarian cancer. A recent study questions the value of this practice, but the clinical trial has significant limitations and discounts the value of early detection to permit treatment of recurrence with novel and conventional agents.